We focus on four areas where Chinese hospitals are genuinely strong, and where international patients are most often stuck. If your diagnosis is not listed here, ask anyway — the free review covers anything.
Five CAR-T products are licensed in China, and hundreds of clinical trials are recruiting. Several are not available, or not affordable, in the US and Europe.
Leukaemia, lymphoma and multiple myeloma — including cases that have relapsed after several lines of treatment.
Cardiac, thoracic, neurosurgical, orthopaedic and hepatobiliary procedures where the surgeon's annual case volume is the single biggest variable.
Implants, full-mouth restoration and complex prosthetics, at a fraction of Western private pricing, without a nine-month waiting list.
No commitment, no fee. If China is not the right answer for your case, we will tell you that first.
What to send: diagnosis, most recent pathology report, treatment history, and latest imaging. Reply within 48 hours.
